Sapan Gai, CCO at Sovereign Metals, discusses their superior graphite test results. Watch the video here.
Would love to see a Merck TR1 increased holding to kick this off - plausible.
We had the 2 x 500k blocks reported first thing also at the same price 41p. Surely large buys of that size on market would not be leading us back into the 39's on a low volume day.
3 Big blocks now showing on the trade data from last night.
2 x 500,000 @41p
1 x 412,000 (approx) @ 40.80p
Hi Shaa, notice the 11am auction UT was 31.50. Close at 33.85? - with all these games will be interesting to see.
Incredible given Cuda paid 48m USD for for 27 percent of Barron flats excl Cole Creek.
My research lead me to this also.
They have high output 3,00 tests per day gold standard antibody capacity at Whitechapel. Company owned hardware utilising the Quotient Mosaiq platform. They want to create a one stop back to work programme for business covering not only Covid but RSV FLu etc.
I’m not convinced. Same MM as has been for 2 months controlling the book. They just want 14 p instead of 13p last week and 12p the month before. Good news is it appears they are in the last throws.
Intrigue and Mystery surrounding contract awards testing revenues and so not helping. Need some meat on those bones. Huge amount to be unleashed here.
JH, all rather bizarre given the placing was 5 times oversubscribed. Should be plenty of demand given SP hovering around placing price. I Imagine The IIs cannot buy in volume so its down to the PIs to take the strain which is backing up progress.
Clearing Acacia is a matter of days. Which other holdings are you expecting to be flipped?
Buying volume pretty pathetic over the last week, seller will take a lot longer to clear out at this rate. Thought the broker was supposed to be mopping up.
Suggest you do a little more research, it’s all out there.
https://raexpert.eu/reports/Press_release_Zenith_Energy_Ltd_27.05.2020.pdf
Pretty dreadful read.
Agree with Ezhik, get tilapia re-licensed and farmed out asap. Report suggests 15m dollars required in development costs -they can't be doing this on their own, sooner AC realises this the better but not really his style.
Because that idiot probably has 1m worth of shared allocated at 11p
No, they do not have the IP being the challenge model or the quarantine facilities. Only orph have carry out on any scale
The caveat there being the placing price was arranged pre Quotient deal so arguably stronger than 11p. 13.5p is where I would add if the chance presents itself. Not fussed either way, here for the end game.
I agree, I struggled to get any below 13p on the open market following the raise. Any creep down will be bought into given the demand.
Some stocks you should just invest in Littlevillage. Good luck with your 11p.
Gold standard antibody venous lab test now open for business and we should give it up? Capillary flow test will never match the former but I believe each will have a place. Watch the contracts come in over the coming days and weeks. The real cost to ORPH here is minimal bar the machine at cost and a handful of lab staff , rewards far outweigh.